Dr. Oz Nomination Advances to Full Senate

by Tim Rowan, Editor Emeritus Dr. Oz Nomination Advance to Senate “Given your close ties to the industry that you would regulate, if you are confirmed, the public would have reason to question your impartiality and commitment to serving the public’s...

Medicare Advantage Stock Prices After Trump Elected

by Kristin Rowan, Editor Will the Change in Leadership Usher in a Change in Reimbursement Rates? As in any election year, we have been bombarded with promises, predictions, and pandering from senate and house hopefuls as well as presidential candidates from every...